While these functional studies implicate the relevance of PPAR-γ function to PCOS, the molecularmechanisms to explain the beneficial action of PPAR-γactivators on the clinical picture of PCOS are still obscure. This evidence concerns the gene PPARG and polycystic ovary syndrome.